Scilex Holding (SCLX) Total Debt (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Total Debt of $80.8 million for Q1 2026, up 104.81% year-over-year from $39.4 million in Q1 2025, and down 23.6% on a QoQ basis from $105.7 million in Q4 2025.

Scilex Holding (SCLX) Total Debt (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Total Debt for 6 consecutive years, with $80.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Debt rose 104.81% year-over-year to $80.8 million; the TTM figure through Mar 2026 stood at $80.8 million (up 104.81% YoY), while the FY2025 annual figure was $105.7 million, up 196.02% from the prior year.
  • Total Debt came in at $80.8 million for Q1 2026 at Scilex Holding, down from $105.7 million in the prior quarter.
  • The five-year high for Total Debt was $125.5 million in Q4 2023, with the low at $2.0 million in Q2 2022.
  • Average Total Debt over 5 years is $66.3 million, with a median of $63.2 million recorded in 2025.
  • Across the five-year window, Total Debt jumped 4010.62% in 2023 and tumbled 71.53% in 2024, its largest moves.
  • Year by year, Total Debt stood at $3.0 million in 2022, then soared by 4122.11% to $125.5 million in 2023, then slumped by 71.53% to $35.7 million in 2024, then surged by 196.02% to $105.7 million in 2025, then declined by 23.6% to $80.8 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods registered $80.8 million, $105.7 million, and $45.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 43.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 54.99 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 64.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -24.45 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 49.12 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 57.32 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 22.17 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 64.46 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -19.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 80.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.78 Mn
Dec 31, 2025 105.74 Mn
Sep 30, 2025 45.67 Mn
Jun 30, 2025 39.87 Mn
Mar 31, 2025 39.44 Mn
Dec 31, 2024 35.72 Mn
Sep 30, 2024 98.97 Mn
Jun 30, 2024 104.40 Mn
Mar 31, 2024 109.25 Mn
Dec 31, 2023 125.47 Mn
Sep 30, 2023 122.15 Mn
Jun 30, 2023 15.92 Mn
Sep 30, 2022 2.97 Mn
Jun 30, 2022 2.00 Mn
Dec 31, 2021 109.99 Mn